Tango Therapeutics Inc (TNGX)

Dec 10, 2025

Stempoint Capital LP Acquires Shares of 208,800 Tango Therapeutics, Inc. $TNGX - MarketBeat

Dec 10, 2025

Dec 09, 2025

Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat

Dec 09, 2025

Dec 09, 2025

Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat

Dec 09, 2025

Dec 09, 2025

Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Finviz

Dec 09, 2025

Dec 06, 2025

Tango Therapeutics CFO Beckman sells $25,281 in stock - MSN

Dec 06, 2025

Dec 05, 2025

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st

Dec 05, 2025

Dec 05, 2025

Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX - MarketBeat

Dec 05, 2025

Dec 05, 2025

How interest rate cuts could boost Tango Therapeutics Inc. stockMarket Risk Analysis & Daily Profit Focused Screening - Newser

Dec 05, 2025

Dec 04, 2025

Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation - Nasdaq

Dec 04, 2025

Dec 04, 2025

Is Tango Therapeutics Inc. stock near bottom after declineJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser

Dec 04, 2025

Dec 03, 2025

Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Piper Sandler Healthcare Conference - marketscreener.com

Dec 03, 2025

Dec 02, 2025

Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat

Dec 02, 2025

Dec 02, 2025

Tango Therapeutics (TNGX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 01, 2025

Can Tango Therapeutics Stock Hold Up When Markets Turn? - Trefis

Dec 01, 2025

Dec 01, 2025

Retail Trends: How interest rate cuts could boost Tango Therapeutics Inc stockRecession Risk & Fast Exit Strategy with Risk Control - BỘ NỘI VỤ

Dec 01, 2025

Nov 28, 2025

Tango Therapeutics Inc trading resumes - MSN

Nov 28, 2025

Nov 28, 2025

Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy - MSN

Nov 28, 2025

Nov 27, 2025

Tango Therapeutics initiated with a Peer Perform at Wolfe Research - MSN

Nov 27, 2025

Nov 27, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 27, 2025

Nov 26, 2025

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 26, 2025

Nov 23, 2025

Tango Therapeutics launches $100M at-the-market stock offering - MSN

Nov 23, 2025

Nov 22, 2025

Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High? - MSN

Nov 22, 2025

Nov 22, 2025

Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week HighTime to Buy? - MarketBeat

Nov 22, 2025

Nov 21, 2025

Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics stock hits 52-week high at 9.7 USD By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal TestingBuy (TNGX) - Seeking Alpha

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics stock hits 52-week high at 9.7 USD - Investing.com India

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics launches new $100 million at-the-market stock offering By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics Inc files for mixed shelf offeringSEC filing - marketscreener.com

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics files prospectus for resale of 1.7 million shares by selling stockholderSEC filing - marketscreener.com

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics launches new $100 million at-the-market stock offering - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Tango Therapeutics Enters New Sales Agreement with Leerink - TipRanks

Nov 21, 2025

Nov 21, 2025

[S-3] Tango Therapeutics, Inc. Shelf Registration Statement | TNGX SEC FilingForm S-3 - Stock Titan

Nov 21, 2025

Nov 21, 2025

[8-K] Tango Therapeutics, Inc. Reports Material Event | TNGX SEC FilingForm 8-K - Stock Titan

Nov 21, 2025

Nov 20, 2025

Why Tango Therapeutics Inc. stock remains on watchlists2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Short interest data insights for Tango Therapeutics Inc.Weekly Trade Review & Accurate Intraday Trade Tips - newser.com

Nov 19, 2025

Nov 19, 2025

How analysts rate Tango Therapeutics Inc. stock todayWeekly Profit Analysis & Growth Focused Investment Plans - newser.com

Nov 19, 2025

Nov 19, 2025

TNGX: Pivotal pancreatic cancer study advances, with strong combo data and cash runway into 2028 - TradingView

Nov 19, 2025

Nov 19, 2025

Will Tango Therapeutics Inc. stock benefit from automationForecast Cut & Short-Term Trading Alerts - newser.com

Nov 19, 2025